1. Home
  2. TNFA vs ADD Comparison

TNFA vs ADD Comparison

Compare TNFA & ADD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNFA
  • ADD
  • Stock Information
  • Founded
  • TNFA 2014
  • ADD 2002
  • Country
  • TNFA United States
  • ADD United States
  • Employees
  • TNFA N/A
  • ADD N/A
  • Industry
  • TNFA
  • ADD Engineering & Construction
  • Sector
  • TNFA
  • ADD Consumer Discretionary
  • Exchange
  • TNFA NYSE
  • ADD Nasdaq
  • Market Cap
  • TNFA 760.1K
  • ADD 613.2K
  • IPO Year
  • TNFA N/A
  • ADD N/A
  • Fundamental
  • Price
  • TNFA $0.17
  • ADD $0.90
  • Analyst Decision
  • TNFA
  • ADD
  • Analyst Count
  • TNFA 0
  • ADD 0
  • Target Price
  • TNFA N/A
  • ADD N/A
  • AVG Volume (30 Days)
  • TNFA 3.4M
  • ADD 448.7K
  • Earning Date
  • TNFA 05-15-2025
  • ADD 06-17-2025
  • Dividend Yield
  • TNFA N/A
  • ADD N/A
  • EPS Growth
  • TNFA N/A
  • ADD N/A
  • EPS
  • TNFA N/A
  • ADD N/A
  • Revenue
  • TNFA N/A
  • ADD $2,830,442.00
  • Revenue This Year
  • TNFA N/A
  • ADD N/A
  • Revenue Next Year
  • TNFA N/A
  • ADD N/A
  • P/E Ratio
  • TNFA N/A
  • ADD N/A
  • Revenue Growth
  • TNFA N/A
  • ADD N/A
  • 52 Week Low
  • TNFA $0.15
  • ADD $0.56
  • 52 Week High
  • TNFA $2.24
  • ADD $185.00
  • Technical
  • Relative Strength Index (RSI)
  • TNFA 41.80
  • ADD 49.60
  • Support Level
  • TNFA $0.16
  • ADD $0.89
  • Resistance Level
  • TNFA $0.19
  • ADD $1.02
  • Average True Range (ATR)
  • TNFA 0.02
  • ADD 0.07
  • MACD
  • TNFA 0.00
  • ADD -0.01
  • Stochastic Oscillator
  • TNFA 29.31
  • ADD 25.00

About TNFA TNF PHARMACEUTICALS INC EFFEC

TNF Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. The company is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. Supera-CBD is a synthetic derivative of CBD being developed to treat various conditions, including epilepsy, pain, and anxiety/depression, through its effects on the CB2 receptor, opioid receptors, and monoamine oxidase enzyme type B.

About ADD Color Star Technology Co. Ltd.

Color Star Technology Co Ltd is an entertainment technology company with a network that focuses on the application of technology and artificial intelligence in the entertainment industry. It provides online entertainment performances and online education through its wholly-owned subsidiaries Color Metaverse and CACM. The curriculum developed by the company includes music, sports, animation, painting and calligraphy, film and television, and life skills, covering various aspects of entertainment, sports, and culture.

Share on Social Networks: